Breast Cancer

The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.

Latest News

FDA Approves Sacituzumab Govitecan-hziy for HR+/HER2- Metastatic Breast Cancer
FDA Approves Sacituzumab Govitecan-hziy for HR+/HER2- Metastatic Breast Cancer

February 3rd 2023

Sacituzumab govitecan-hziy (Trodelvy) is a conjugated Trop-2-directed antibody and topoisomerase inhibitor previously approved for patients with triple-negative breast cancer.

FDA Approves Elacestrant for ER+/HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer
FDA Approves Elacestrant for ER+/HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer

January 28th 2023

Study Finds Increased Cancer Mortality in Patients With Type 2 Diabetes
Study Finds Increased Cancer Mortality in Patients With Type 2 Diabetes

January 27th 2023

Research Finds CAR T-Cell Therapy May Eliminate Tumor Cells Left After Surgery
Research Finds CAR T-Cell Therapy May Eliminate Tumor Cells Left After Surgery

January 23rd 2023

FDA Grants Accelerated Approval to Tucatinib Combination for Patients with HER2-Positive Metastatic Colorectal Cancer
FDA Grants Accelerated Approval to Tucatinib Combination for Patients with HER2-Positive Metastatic Colorectal Cancer

January 20th 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.